Quantcast

Latest Prostate-specific antigen Stories

2011-07-21 08:00:00

CAMBRIDGE, Mass., July 21, 2011 /PRNewswire/ -- Quanterix Corporation, an in-vitro diagnostics (IVD) company providing life science researchers and IVD labs single molecule technology with unprecedented sensitivity and precision, announced that the analytical performance of AccuPSA(TM), a fifth-generation digital immunoassay for Prostate Specific Antigen (PSA), demonstrated a robust 2-log improvement in sensitivity over today's ultrasensitive third-generation assays for measuring PSA in...

2011-07-14 13:07:50

Short-term hormone therapy (androgen deprivation therapy: ADT) given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with that of those who receive the same radiation therapy alone, according to a Radiation Therapy Oncology Group (RTOG) study published in the July 14 issue of the New England Journal of Medicine. This largest randomized trial of its kind enrolled nearly 2,000 men at...

2011-07-13 13:55:27

The widely known PSA blood test for prostate cancer in men may get a second life as a much-needed new test for breast cancer, the most common form of cancer in women worldwide, scientists are reporting in a new study in the ACS journal Analytical Chemistry. Chien Chou and colleagues say that the prostate-specific antigen (PSA) measured in the test also is a potential biomarker of breast cancer in women. However, levels of PSA in healthy women are usually so small that only ultrasensitive...

2011-07-12 12:45:27

Doctors have known for a long time that prostate cancer "runs in the family". Men with relatives who have been diagnosed with prostate cancer have an elevated risk of also developing this type of cancer. It was only last year that DKFZ scientists calculated that this risk rises with the number of affected direct family members and also depends on the relatives' age at outbreak of the disease (DKFZ Press Release 18/2010). The exact DNA variants that contribute to prostate cancer risk have now...

2011-06-15 07:48:00

-20-month extension of the Gen-Probe license- QUEBEC CITY, June 15, 2011 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported the issuance of a new U.S. patent, which represents a significant addition to DiagnoCure's PCA3 prostate cancer biomarker portfolio. Moreover, in addition to providing greater patent protection, this new patent bears an extended expiration...

2011-06-10 13:24:02

Receiving radiation therapy immediately after a radical prostatectomy is a cost-effective treatment for prostate cancer patients when compared with waiting and acting on elevated prostate-specific antigen (PSA) levels, according to a new study by researchers at Thomas Jefferson University and Hospital. What's more, a separate, but related study, found that urologists were less likely than radiation oncologists to recommend adjuvant radiation therapy or to believe it improves overall...

2011-06-06 16:42:00

NEW YORK, June 6, 2011 /PRNewswire/ -- According to research presented by Dr. David B. Samadi, a prostate cancer treatment, robotic prostatectomy, and prostate surgery expert, at the annual meeting of the American Urological Association men taking statins, a class of widely used cholesterol-lowering drugs, have significantly lower serum PSA (prostate-specific antigen) levels than their non statin-using counterparts. (Photo: http://photos.prnewswire.com/prnh/20110606/NY14928 ) This PSA...

2011-06-02 09:34:00

BENTONVILLE, Ark., June 2, 2011 /PRNewswire/ -- Many of the major health risks that men face can be prevented and treated if they are diagnosed early, so getting the right screening test at the right time is one of the most important things a man can do for his health. In honor of Men's Health Month, Sam's Club will be offering free men's health screening tests on Saturday, June 11 from 11 a.m. to 3 p.m. The screenings, conducted by Carmen Ingle & Associates, will include a...

2011-05-23 14:14:38

Some men of African descent may have a higher genetic risk of developing prostate cancer, according to research conducted at the Keck School of Medicine of the University of Southern California (USC). The genome-wide association study, published in the journal Nature Genetics on May 22, determined a marker of risk for prostate cancer in men of African descent, who tend to more susceptible to prostate cancer than men of non-African descent. The research team was led by Christopher Haiman,...

2011-05-18 16:13:25

New study defuses controversy, shows why individual patient trends are critical A man's rising PSA (prostate-specific antigen) level over several years "“ which had been seen as a possible warning sign of prostate cancer "“ has recently come under fire as a screening test because it sometimes prompts biopsies that turn out to be normal. A new study, however, shows nearly 70 percent of men who had rising PSA levels and subsequent normal biopsies were eventually diagnosed with...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related